DEVELOPING MECHANISM-BASED THERAPEUTIC STRATEGIES FOR AGGRESSIVE RARE KIDNEY CANCER.

$1,061,984FY2021Defense Health AgencyDOD

Sloan-Kettering Institute For Cancer Research

Investigators